Trademark: 79164322
Word
3RND
Status
Registered
Status Code
707
Status Date
Thursday, May 25, 2023
Serial Number
79164322
Registration Number
4943582
Registration Date
Tuesday, April 26, 2016
Mark Type
4000
Filing Date
Saturday, March 14, 2015
Published for Opposition
Tuesday, February 9, 2016

Trademark Owner History
AsedaSciences AG - Original Registrant

Classifications
9 [ Database management software; software for application and database integration; software for creating searchable databases; computer application software for mobile phones, cellular phones, handheld computers, smart telephones, PC tablets, personal digital assistants, mobile computers, computers, namely, software used for analysis, storage, data retrieval and visualization of compounds and the cellular effect of compounds in drug discovery; bioinformatics software used to assess the cellular effect of compounds in the drug discovery and development process; computer graphics software; software for accessing information directories that may be downloaded from a global computer network; software for data storage automation; data search software, namely, software for creating searchable database of data; digital image processing software; software for data and document capture, transmission, storage and indexing; scanning software ]
42 [ Scientific research and development; ] scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing [ services and protein isolation ] for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect [, and scientific research and development relating thereto ] ; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, drug discovery and characterization of compound effect [, and protein separation, isolation and characterization ] ; [ scientific research services; ] scientific testing and analysis in the fields of pharmaceutical research, drug discovery and characterization of compound effect [, and protein separation, isolation and characterization ] ; computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; [ laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; pharmaceutical research and development; ] Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; ] provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; [ provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and ] scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]
THREE ROUND

Trademark Events
Mar 17, 2024
Partial Invalidation Processed By The Ib
Feb 3, 2024
Partial Invalidation Of Reg Ext Protection Sent To Ib
Feb 2, 2024
Invalidation Processed
Jan 25, 2024
Partial Invalidation Of Reg Ext Protection Created
May 25, 2023
Notice Of Acceptance Of Sec. 71 - E-Mailed
May 25, 2023
Registered - Partial Sec 71 Accepted
May 16, 2023
Case Assigned To Post Registration Paralegal
Oct 25, 2022
Teas Section 71 Received
Apr 26, 2021
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Aug 12, 2016
Final Decision Transaction Processed By Ib
Jul 27, 2016
Final Disposition Notice Sent To Ib
Jul 27, 2016
Final Disposition Processed
Jul 26, 2016
Final Disposition Notice Created, To Be Sent To Ib
Apr 26, 2016
Registered-Principal Register
Feb 9, 2016
Official Gazette Publication Confirmation E-Mailed
Feb 9, 2016
Published For Opposition
Feb 5, 2016
Notification Processed By Ib
Jan 20, 2016
Notification Of Possible Opposition Sent To Ib
Jan 20, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 20, 2016
Notification Of Notice Of Publication E-Mailed
Jan 4, 2016
Approved For Pub - Principal Register
Dec 17, 2015
Examiner's Amendment Entered
Dec 17, 2015
Notification Of Examiners Amendment E-Mailed
Dec 17, 2015
Examiners Amendment E-Mailed
Dec 17, 2015
Examiners Amendment -Written
Oct 29, 2015
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 29, 2015
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 11, 2015
Refusal Processed By Ib
Jun 22, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Jun 22, 2015
Refusal Processed By Mpu
Jun 19, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Jun 18, 2015
Non-Final Action Written
Jun 18, 2015
Assigned To Examiner
May 6, 2015
Application Filing Receipt Mailed
May 2, 2015
New Application Office Supplied Data Entered
Apr 30, 2015
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24